Study of Elevated Plasma D-dimer Levels and Their Link to Inflammation and Survival in Adults with Community-Acquired Pneumonia

What this Trial Is About

This research aims to explore how high levels of plasma D-dimer relate to the inflammatory response and survival outcomes in adults diagnosed with community-acquired pneumonia CAP. CAP is a common infection that can be serious and affects many people worldwide. The study focuses on understanding the link between D-dimer levels, inflammation severity, and patient survival. Participants in this observational study will include adults aged 18 and older diagnosed with CAP based on symptoms, lab tests, and chest X-rays, excluding those with signs of COVID-19 pneumonia. Each participant will have blood samples taken to measure D-dimer levels, along with assessments including a full medical history, clinical examination, laboratory tests like white blood cell count and C-reactive protein, and radiological findings. Severity of illness will also be evaluated using the CURB-65 score. Throughout the study, researchers will monitor the correlation between D-dimer levels and the severity of pneumonia over six months. Participants will undergo standard clinical assessments and laboratory tests without receiving experimental treatments. The study will collect and analyze data to better understand how inflammation and D-dimer levels affect outcomes in CAP patients, with no additional interventions beyond routine care.

Association Between Plasma D Dimer in Adult CAP and Severity of Inflammatory Response and Survival